COVID 19 Exposing Risks in the Medical Devices Supply Chain

June 30, 2020
Webcast , Countries

This webcast examines the impact COVID-19 has had on supply chains and explores some of the challenges medical device manufacturers and supply chains could be facing.

Schedule 11:00 a.m. – 12:00 p.m. EST (4:00 p.m. – 5:00 p.m. BST) 

Register now.

Prior to COVID-19 companies were already having to adjust to new or evolving geopolitical and cyber risks impacting their supply chain. While these risks were substantial, COVID-19 is forcing many companies—and even entire industries—to rethink and transform their global supply chain model. Some of these reasons include:

  • Companies are being forced to abruptly shift to new business models in ways that significantly alter their risk and resilience.
  • Supply chains, already a target of economic nationalism in some countries, now face new questions about risk concentration.
  • Revenues are falling globally under twin blows of production disruptions and weakening demand with a ripple effect among third party vendors and contractors.

While COVID-19 may be the catalyst for companies to revisit their global supply chain strategy and accelerate the adoption of new models and capabilities, short-term actions need to be made to respond to the immediate challenge

Please join our experts in understanding how to approach some of the key risks currently being faced.


  • Tom Hollobone, Associate Managing Director, Compliance Risk and Diligence, Kroll, a division of Duff & Phelps
  • Daniel Hartnett, Associate Managing Director, Compliance Risk and Diligence at Kroll, a division of Duff & Phelps
  • Dan Harris, Attorney and Managing Partner at Harris Bricken, International Law Firm

Register now.

Compliance Risk and Diligence

The Kroll Investigations, Diligence and Compliance team partners with clients to anticipate, detect and manage regulatory and reputational risks associated with global ethics and compliance obligations.

Compliance Program Consulting

Kroll is trusted by companies worldwide to help establish policies and programs aimed toward preventing fraud and complying with anti-money laundering (AML) and anti-bribery and corruption regulations.

AML Compliance Due Diligence

Kroll helps clients navigate the complexities of today’s regulatory environment through a broad suite of anti-money laundering compliance screening and due diligence offers.

Due Diligence Wizard Tool

Determine which due diligence product best fits your needs.

Compliance Portal

Your Process. Our Technology.